Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 1;147(9):828-831.
doi: 10.1001/jamaoto.2021.1456.

A Rapid Olfactory Test as a Potential Screening Tool for COVID-19

Affiliations

A Rapid Olfactory Test as a Potential Screening Tool for COVID-19

Mena Said et al. JAMA Otolaryngol Head Neck Surg. .

Abstract

This prospective study assesses the feasibility of a novel, objective olfactory test as part of an initial screening for COVID-19 in adults with unknown disease status.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Davis is the founder of SAFER Diagnostics. No other disclosures were reported.

Similar articles

Cited by

References

    1. Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10(7):806-813. doi:10.1002/alr.22579 - DOI - PMC - PubMed
    1. Gerkin RC, Ohla K, Veldhuizen MG, et al. ; GCCR Group Author . Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms. Chem Senses. 2021;46:bjaa081. doi:10.1093/chemse/bjaa081 - DOI - PMC - PubMed
    1. Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;10(8):944-950. doi:10.1002/alr.22587 - DOI - PMC - PubMed
    1. Hoffman HJ, Rawal S, Li C-M, Duffy VB. New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016;17(2):221-240. doi:10.1007/s11154-016-9364-1 - DOI - PMC - PubMed
    1. Zhu J, Ji P, Pang J, et al. . Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;92(10):1902-1914. doi:10.1002/jmv.25884 - DOI - PMC - PubMed

Publication types